Search research articles
Contact Us
Filters
Showing results (81-90 of 182) with videos related to
Page
of 19
Sort By:
Cancer Research
|
June 23, 2018
CD271<sup>+</sup> Cells Are Diagnostic and Prognostic and Exhibit Elevated MAPK Activity in SHH Medulloblastoma
Lisa Liang, Ludivine Coudière-Morrison, Nazanin Tatari, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 2010
Multivitamin use is not associated with cancer recurrence or survival in patients with stage III colon cancer: findings from CALGB 89803
Kimmie Ng, Jeffrey A Meyerhardt, Jennifer A Chan, et al.
JAMA
|
June 5, 2008
Association of family history with cancer recurrence and survival among patients with stage III colon cancer
Jennifer A Chan, Jeffrey A Meyerhardt, Donna Niedzwiecki, et al.
Nature Communications
|
January 18, 2019
The CHD6 chromatin remodeler is an oxidative DNA damage response factor
Shaun Moore, N Daniel Berger, Martijn S Luijsterburg, et al.
Neuro-Oncology
|
December 7, 2013
A novel C19MC amplified cell line links Lin28/let-7 to mTOR signaling in embryonal tumor with multilayered rosettes
Tara Spence, Christian Perotti, Patrick Sin-Chan, et al.
Annals of Neurology
|
June 22, 2012
DNA hypermethylation and 1p Loss silence NHE-1 in oligodendroglioma
Michael D Blough, Mohammad Al-Najjar, Charles Chesnelong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 7, 2017
Phase III Prospective Randomized Comparison Trial of Depot Octreotide Plus Interferon Alfa-2b Versus Depot Octreotide Plus Bevacizumab in Patients With Advanced Carcinoid Tumors: SWOG S0518
James C Yao, Katherine A Guthrie, Cesar Moran, et al.
Nucleic Acids Research
|
October 3, 2020
A high-throughput alpha particle irradiation system for monitoring DNA damage repair, genome instability and screening in human cell and yeast model systems
Fintan K T Stanley, N Daniel Berger, Dustin D Pearson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 5, 2020
NANETS/SNMMI Consensus Statement on Patient Selection and Appropriate Use of <sup>177</sup>Lu-DOTATATE Peptide Receptor Radionuclide Therapy
Thomas A Hope, Lisa Bodei, Jennifer A Chan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 28, 2013
Prognostic significance of MTOR pathway component expression in neuroendocrine tumors
Zhi Rong Qian, Monica Ter-Minassian, Jennifer A Chan, et al.
Page
of 19
Search research articles
Search
Showing results (81-90 of 182) with videos related to
Sort By:
Page
of 19
Cancer Research
|
June 23, 2018
CD271<sup>+</sup> Cells Are Diagnostic and Prognostic and Exhibit Elevated MAPK Activity in SHH Medulloblastoma
Lisa Liang, Ludivine Coudière-Morrison, Nazanin Tatari, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 2010
Multivitamin use is not associated with cancer recurrence or survival in patients with stage III colon cancer: findings from CALGB 89803
Kimmie Ng, Jeffrey A Meyerhardt, Jennifer A Chan, et al.
JAMA
|
June 5, 2008
Association of family history with cancer recurrence and survival among patients with stage III colon cancer
Jennifer A Chan, Jeffrey A Meyerhardt, Donna Niedzwiecki, et al.
Nature Communications
|
January 18, 2019
The CHD6 chromatin remodeler is an oxidative DNA damage response factor
Shaun Moore, N Daniel Berger, Martijn S Luijsterburg, et al.
Neuro-Oncology
|
December 7, 2013
A novel C19MC amplified cell line links Lin28/let-7 to mTOR signaling in embryonal tumor with multilayered rosettes
Tara Spence, Christian Perotti, Patrick Sin-Chan, et al.
Annals of Neurology
|
June 22, 2012
DNA hypermethylation and 1p Loss silence NHE-1 in oligodendroglioma
Michael D Blough, Mohammad Al-Najjar, Charles Chesnelong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 7, 2017
Phase III Prospective Randomized Comparison Trial of Depot Octreotide Plus Interferon Alfa-2b Versus Depot Octreotide Plus Bevacizumab in Patients With Advanced Carcinoid Tumors: SWOG S0518
James C Yao, Katherine A Guthrie, Cesar Moran, et al.
Nucleic Acids Research
|
October 3, 2020
A high-throughput alpha particle irradiation system for monitoring DNA damage repair, genome instability and screening in human cell and yeast model systems
Fintan K T Stanley, N Daniel Berger, Dustin D Pearson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 5, 2020
NANETS/SNMMI Consensus Statement on Patient Selection and Appropriate Use of <sup>177</sup>Lu-DOTATATE Peptide Receptor Radionuclide Therapy
Thomas A Hope, Lisa Bodei, Jennifer A Chan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 28, 2013
Prognostic significance of MTOR pathway component expression in neuroendocrine tumors
Zhi Rong Qian, Monica Ter-Minassian, Jennifer A Chan, et al.
Page
of 19